Endolysosomal sorting of ubiquitylated caveolin-1 is regulated by VCP and UBXD1 and impaired by VCP disease mutations-Reference-Cited by-同舟云学术

Endolysosomal sorting of ubiquitylated caveolin-1 is regulated by VCP and UBXD1 and impaired by VCP disease mutations

Published:2011-08-07 Issue:9 Volume:13 Page:1116-1123
ISSN:1465-7392
Container-title:Nature Cell Biology
language:en
Short-container-title:Nat Cell Biol

Author:

Ritz Danilo,Vuk Maja,Kirchner Philipp,Bug Monika,Schütz Sabina,Hayer Arnold,Bremer Sebastian,Lusk Caleb,Baloh Robert H.,Lee Houkeun,Glatter Timo,Gstaiger Matthias,Aebersold Ruedi,Weihl Conrad C.,Meyer Hemmo

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology

Link

http://www.nature.com/articles/ncb2301.pdf

Reference40 articles.

1. Jentsch, S. & Rumpf, S. Cdc48 (p97): A ‘molecular gearbox’ in the ubiquitin pathway? Trends Biochem. Sci. 32, 6–11 (2007).

2. Meyer, H. & Popp, O. Role(s) of Cdc48/p97 in mitosis. Biochem. Soc. Trans. 36, 126–130 (2008).

3. Ye, Y. Diverse functions with a common regulator: ubiquitin takes command of an AAA ATPase. J. Struct. Biol. 156, 29–40 (2006).

4. Watts, G. D. et al. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat. Genet. 36, 377–381 (2004).

5. Weihl, C. C., Pestronk, A. & Kimonis, V. E. Valosin-containing protein disease: inclusion body myopathy with Paget’s disease of the bone and fronto-temporal dementia. Neuromuscul. Disord. 19, 308–315 (2009).

Cited by 211 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TEX264 drives selective autophagy of DNA lesions to promote DNA repair and cell survival;Cell;2024-09

2. Mechanism of allosteric inhibition of human p97/VCP ATPase and its disease mutant by triazole inhibitors;Communications Chemistry;2024-08-09

3. Allosteric activation of VCP, an AAA unfoldase, by small molecule mimicry;Proceedings of the National Academy of Sciences;2024-06-04

4. Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS;Nature Medicine;2024-06

5. VCP activator reverses nuclear proteostasis defects and enhances TDP-43 aggregate clearance in multisystem proteinopathy models;Journal of Clinical Investigation;2024-05-23